Pagas, Cyril .

HRN: 22-17-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/29/2023
IV
1.5gm
Q8
Gravdio Cardiac
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: